Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where A H Kang is active.

Publication


Featured researches published by A H Kang.


Journal of Clinical Investigation | 1987

Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.

Arnold E. Postlethwaite; Jorma Keski-Oja; Harold L. Moses; A H Kang

Transforming growth factor-beta (TGF beta), when injected subcutaneously into newborn mice, induces a rapid fibrotic response, stimulates chemotaxis, and elevates the rates of biosynthesis of collagen and fibronectin by fibroblasts in vitro. We explored the molecular mechanisms of TGF beta-mediated stimulation of collagen and fibronectin synthesis in cultured human foreskin fibroblasts. TGF beta preferentially stimulated the synthesis of fibronectin and type I procollagen chains 3-5-fold as shown by polypeptide analysis. Concomitant elevation in the steady state levels of messenger RNAs (mRNAs) coding for type I procollagen and fibronectin also occurred but without a net increase in the rate of transcription of either of these genes. The preferential stabilization of mRNAs specifying type I procollagen and fibronectin provides a partial explanation for the mechanisms by which TGF beta enhances the synthesis of type I procollagen and fibronectin in mesenchymal cells.


Journal of Clinical Investigation | 1985

Profiles of steady state levels of messenger RNAs coding for type I procollagen, elastin, and fibronectin in hamster lungs undergoing bleomycin-induced interstitial pulmonary fibrosis.

S Lurie; Jerome M. Seyer; A H Kang

We have characterized the messenger RNAs (mRNAs) coding for procollagen alpha 1(I), elastin, fibronectin, and actin in the lungs of Syrian golden hamsters by Northern blot analyses. While elastin, fibronectin, and beta-actin were each coded for by a single mRNA species of 4.1 kilobases (kb), 9.1 kb, and 2.1 kb in size, respectively, we identified a major (5.4 kb) and a minor (6.5 kb) procollagen alpha 1(I) mRNA species in the hamster lungs. The mRNAs for the three extracellular matrix proteins showed increased accumulation followed by steady decline in the bleomycin-treated lungs. There were significant differences among the three mRNAs in the relative increase and the time of maximum accumulation. After reaching the peak levels between 2-3 wk posttreatment, the levels of procollagen alpha 1(I) and elastin mRNAs declined to near normal values around the fourth week. In contrast, the accumulation of fibronectin mRNA was maximum in the first week after bleomycin treatment. The procollagen alpha 1(I) mRNA accumulated most dramatically (sevenfold above the levels in the untreated animals) compared with a five-fold increase in mRNA coding for fibronectin. Elastin mRNA increased approximately twofold above the control values. Nuclear runoff transcription experiments demonstrated a selective increase in the rates of transcription of genes coding for procollagen alpha 1(I), fibronectin, and elastin; the extent of transcriptional stimulation of procollagen alpha 1(I) and fibronectin genes was significantly greater than that of elastin. Since the amount of actin mRNA, as well as the rate of transcription of actin gene(s), varied only slightly after bleomycin treatment, we conclude that the metabolism of mRNAs coding for extracellular matrix proteins may be preferentially perturbed during pulmonary fibrosis.


Biochemical and Biophysical Research Communications | 1980

Type-specific collagenolysis: a type V collagen-degrading enzyme from macrophages.

Carlo L. Mainardi; Jerome M. Seyer; A H Kang

Abstract An enzymatic activity capable of degrading type V collagen at neutral pH was found in the medium from cultured rabbit pulmonary alveolar macrophages which had been “activated” in vivo by injection of complete Freunds Adjuvant. This enzyme was characterized as a metalloproteinase by virtue of its inhibition by EDTA but not by phenylmethylsulfonyl fluoride or N-ethyl maleimide. Ion-exchange chromatography on DEAE-cellulose was successful in separating the type V collagen-degrading activity from the type I collagenase which is also secreted by these cells. These observations suggest that the degradation of type V collagen is independent of the degradation of the interstitial collagens and may require the action of its own “specific collagenase”.


Journal of Clinical Investigation | 1989

Stimulation of glycosaminoglycan synthesis in cultured human dermal fibroblasts by interleukin 1. Induction of hyaluronic acid synthesis by natural and recombinant interleukin 1s and synthetic interleukin 1 beta peptide 163-171.

Arnold E. Postlethwaite; Gerald N. Smith; L B Lachman; Robert O. Endres; Helen M. Poppleton; Karen A. Hasty; Jerome M. Seyer; A H Kang

Hyaluronic acid (HA) is believed to play a critical role in wound healing and in morphogenesis. Factors controlling the production of HA by fibroblasts in normal and pathological states are not completely understood. In this report we have observed that natural human interleukin (IL-1)1 beta and human recombinant (hrIL)-1 alpha and beta are potent stimulators of HA production by fibroblasts in vitro. Hyaluronic acid is the major species of glycosaminoglycan (GAG) stimulated by IL-1 in fibroblasts. PGE2 does not appear to be involved directly in this IL-1 effect on fibroblasts, but stimulation of HA production by IL-1 is dependent on protein synthesis. The synthetic human IL-1 beta peptide 163-171 (Val-Gln-Gly-Glu-Glu-Ser-Asn-Asp-Lys), which has been previously shown to stimulate thymocyte proliferation but not fibroblast PGE2 production, is also able to stimulate fibroblast HA production. The synthesis and secretion of IL-1 by mononuclear phagocytes at sites of inflammation and immune reactions in vivo could potentially serve as a signal for fibroblasts to synthesize HA, which in turn could serve to facilitate and modulate reparative and immune processes by virtue of its ability to alter cell-cell, cell matrix, and cell-membrane receptor interactions.


Immunology | 1999

Intravenous tolerization with type II collagen induces interleukin-4-and interleukin-10-producing CD4+ T cells

M.L. Gumanovskaya; Linda K. Myers; Edward F. Rosloniec; J M Stuart; A H Kang

Intravenous (i.v.) administration of type II collagen (CII) is an effective way to induce tolerance and suppress disease in the collagen‐induced arthritis (CIA) model. In this study, we demonstrated that a single i.v. dose of CII (as low as 0·1 mg/mouse) completely prevented the development of CIA. This suppression was accompanied by decreases in levels of antibody specific for the immunogen, bovine CII and autoantigen, mouse CII. Splenocytes obtained from CII‐tolerized mice and stimulated with CII in vitro produced predominantly the T helper 2 (Th2)‐type cytokines interleukin‐4 (IL‐4) and interleukin‐10 (IL‐10). In contrast, cells obtained from mice immunized with CII produced predominantly interferon‐γ (IFN‐γ). Two‐colour flow cytometric analysis of cytokine expression and T‐cell phenotype demonstrated that CD4+ cells and not CD8+ or γδ+ cells were the predominant regulatory cells producing IL‐4 and IL‐10. Transgenic mice bearing a T‐cell receptor (TCR) specific for CII had a greater increase in the number of IL‐4‐secreting CD4+ cells, as well as a marked increase of IL‐4 in culture supernatants. This cytokine was produced by transgene‐bearing T cells. Elucidation of mechanisms for the induction of tolerance in mature T cells is an important line of study in autoimmune models because of the potential application for treating organ‐specific autoimmune disease.


Biochemical and Biophysical Research Communications | 1979

Ectoprotein kinase activity of the isolated rat adipocyte

Ellen S. Kang; Ronald E. Gates; Thomas M. Chiang; A H Kang

Intact adipocytes exhibit ectoprotein kinase activity as reflected by their ability to catalyze the transfer of the terminal phosphate of (γ-32P) ATP to histone added to a cell suspension. This activity is substrate, time and cell number dependent. Lineweaver-Burk plots gave Km and Vmax values for ATP of 5 × 10−5 M and 7.14 pmoles/min/1.5 × 105 cells. Cyclic AMP but not cyclic GMP in μM concentrations stimulates ectoprotein kinase activity. The controlled tryptic digestion of intact cells results in reduction of ectoprotein kinase activity. This activity is not due to leakage of intracellular protein kinases during the preparative procedure nor to penetration of histone into the cells. Additional phosphoproteins not accessible to endogenous protein kinase activity are also localized on the external surface of the intact fat cell.


Biochemistry | 1975

Covalent structure of collagen: amino acid sequence of alpha1-CB6A of chick skin collagen.

Dixit Sn; Jerome M. Seyer; Oronsky Ao; Clare Corbett; A H Kang; Jerome Gross

The amino acid sequence of chick skin collagen alpha1-CB6A, a peptide containing 107 residues obtained from the helical region near the carboxy-terminus of the alpha1(I) chain by cyanogen bromide cleavage, has been determined. This was accomplished by automated Edman degradation of the hydroxylamine-produced fragments and of the tryptic peptides prepared with and without prior maleylation. The data show that this portion of the alpha1(I) chain from chick skin is identical in 90 percent of the residues to the corresponding peptide region of calf skin collagen reported previously.


Biochemistry | 1975

Covalent structure of collagen: amino acid sequence of alpha1-CB3 of chick skin collagen.

Dixit Sn; A H Kang; Jerome Gross

The amino acid sequence of alpha1-CB3, a peptide containing 149 residues obtained from the central portion of the alpha1(I) chain of chick skin collagen by cyanogen bromide cleavage, has been determined. As in the other sequences from the helical region of collagen chains, the repeating triplet Gly-X-Y extends throughout the length of the peptide. These data allow a comparison of the sequence to that of alpha1-CB3 from calf and rat skin collagens. As compared with calf, the chick peptide contains 14 amino acid differences, whereas it contains 17 residue differences from the rat peptide. Thus, the sequence identity level is 91 and 89 percent, respectively, in comparison to the calf and rat peptides. These values are significantly greater than the value of 97 percent observed between the peptide of the two mammalian species and reflect the greater phylogenetic distance of the species compared.


Journal of Clinical Investigation | 1991

Interleukin 1 stimulates phosphatidylinositol kinase activity in human fibroblasts.

Leslie R. Ballou; S C Barker; Arnold E. Postlethwaite; A H Kang

IL-1 mediates multiple cellular immune and inflammatory responses, but little is known of the intracellular biochemical mechanisms involved in IL-1 actions. We studied the effects of IL-1 on phosphatidylinositol (PtdIns) metabolism and confirmed reports indicating that IL-1 does not stimulate increased PtdIns turnover; however, we observed the accumulation of PtdIns-4-phosphate (PtdInsP) in response to IL-1. Using a fibroblast membrane preparation, we were able to detect stimulated PtdInsP accumulation within 10 s of IL-1 addition. Increased PtdInsP accumulation was due to stimulated PtdIns kinase activity, not the inhibition of PtdInsP hydrolysis by phospholipase(s). PtdIns kinase activity was magnesium dependent, increased as a function of IL-1 concentration, and specifically phosphorylated the D4 position of inositol. Stimulated PtdIns kinase activity could be detected at 10(-12) M IL-1 in fibroblast membranes, a concentration within the physiological range for IL-1 action; half-maximal activity was reached at approximately 10(-10) M IL-1. Heat denaturation of IL-1 or treatment of IL-1 with anti-IL-1 antibody abrogated the IL-1 effect. These findings demonstrate the direct, IL-1-mediated, stimulation of PtdIns kinase. IL-1-stimulated PtdIns kinase activity represents an important physiological regulatory effect by IL-1 as it could control the synthesis and/or maintenance of phosphorylated derivatives of PtdIns which comprise only a very small pool of substrates for the generation of the second messengers inositol 1,4,5-triphosphate and diacylglycerol.


Cellular Immunology | 1982

Characterization of fibroblast proliferation factors elaborated by antigen- and mitogen-stimulated guinea pig lymph node cells: differentiation from lymphocyte-derived chemotactic factor for fibroblasts, lymphocyte mitogenic factor, and interleukin 1.

Arnold E. Postlethwaite; A H Kang

Abstract Guinea pig lymph node cells stimulated in culture by T-cell mitogens or sensitizing antigens release ~60,000- and ~16,000-mol wt proteins that induce normal guinea pig fibroblasts to proliferate in vitro . These fibroblast proliferation factors can be separated from lymphocytederived chemotactic factor for fibroblasts and from lymphocyte mitogenic factor by gel filtration employing Sephadex G-100. The 16,000-mol wt fibroblast proliferation factor was found to coelute with interleukin 1 (IL 1) from gel filtration columns. When the 16,000 molecular weight factor was further analyzed by anion exchange-high-performance liquid chromatography five major peaks containing IL 1 activity were obtained, only one contained fibroblast proliferation activity, suggesting forms of IL 1 exist that are not mitogenic for fibroblast. Occasionally, a large-molecular-weight inhibitor of fibroblast proliferation was detectable in void volume fractions from gel filtration of supernatant from antigen-stimulated lymph node cell cultures. This inhibition was accompanied by gross aggregation of fibroblasts. These studies suggest that fibroblast accumulation at sites of certain cell-mediated immune reactions in vivo may in part be attributable to the release of mediators by lymphocytes and, or macrophages that induce fibroblast growth.

Collaboration


Dive into the A H Kang's collaboration.

Top Co-Authors

Avatar

Jerome M. Seyer

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Arnold E. Postlethwaite

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

J M Stuart

United States Department of Veterans Affairs

View shared research outputs
Top Co-Authors

Avatar

Michael A. Cremer

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Linda K. Myers

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Carlo L. Mainardi

United States Department of Veterans Affairs

View shared research outputs
Top Co-Authors

Avatar

John M. Stuart

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Karen A. Hasty

University of Tennessee Health Science Center

View shared research outputs
Top Co-Authors

Avatar

Thomas M. Chiang

University of Tennessee Health Science Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge